These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21575901)

  • 1. Autologous haematopoietic stem cell transplantation in a patient with refractory Crohn's disease.
    Kountouras J; Sakellari I; Tsarouchas G; Tsiaousi E; Michael S; Zavos C; Anastasiadou K; Stergiopoulos C; Anagnostopoulos A
    J Crohns Colitis; 2011 Jun; 5(3):275-6. PubMed ID: 21575901
    [No Abstract]   [Full Text] [Related]  

  • 2. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
    Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
    Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.
    Hommes DW; Duijvestein M; Zelinkova Z; Stokkers PC; Ley MH; Stoker J; Voermans C; van Oers MH; Kersten MJ
    J Crohns Colitis; 2011 Dec; 5(6):543-9. PubMed ID: 22115372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of budesonide and mesalamine for active Crohn's disease.
    Lowry PW; Sandborn WJ
    Gastroenterology; 1999 May; 116(5):1263. PubMed ID: 10220523
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose intravenous cyclosporine in steroid refractory attacks of inflammatory bowel disease.
    Hermida-Rodriguez C; Cantero Perona J; Garcia-Valriberas R; Pajares Garcia JM; Mate-Jimenez J
    Hepatogastroenterology; 1999; 46(28):2265-8. PubMed ID: 10521978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful autologous haematopoietic stem cell transplantation in severe, therapy-resistant childhood Crohn's disease. Report on the first case in Hungary].
    Kriván G; Szabó D; Kállay K; Benyó G; Kassa C; Sinkó J; Goda V; Arató A; Veres G
    Orv Hetil; 2014 May; 155(20):789-92. PubMed ID: 24819188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
    J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.
    Thomsen OO; Cortot A; Jewell D; Wright JP; Winter T; Veloso FT; Vatn M; Persson T; Pettersson E
    N Engl J Med; 1998 Aug; 339(6):370-4. PubMed ID: 9691103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
    Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
    Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
    Ford AC
    Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in the management of Crohn's disease.
    Caprilli R; Angelucci E; Clemente V
    Dig Liver Dis; 2008 Sep; 40(9):709-16. PubMed ID: 18430617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
    Kim PS; Zlatanic J; Korelitz BI; Gleim GW
    Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
    Reinisch W; Stange EF;
    Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
    [No Abstract]   [Full Text] [Related]  

  • 14. Review article: prevention of postsurgical relapse and recurrence in Crohn's disease.
    Cottone M; Orlando A; Viscido A; Calabrese E; Cammà C; Casà A
    Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():38-42. PubMed ID: 12786611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE; Hanauer SB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
    Hayee BH; Harris AW
    Gastroenterology; 2005 Jan; 128(1):249; author reply 249-51. PubMed ID: 15633158
    [No Abstract]   [Full Text] [Related]  

  • 17. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
    Feagan BG
    Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
    [No Abstract]   [Full Text] [Related]  

  • 18. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
    Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission and relapse of Crohn's disease following autologous haematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
    Anumakonda V; Hayee B; Chung-Faye G
    Gut; 2007 Sep; 56(9):1325. PubMed ID: 17438083
    [No Abstract]   [Full Text] [Related]  

  • 20. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
    Feagan BG; Sandborn WJ
    Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.